换一批Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
第一作者：
V,Gandhi
第一单位：
Departments of Experimental Therapeutics, Biostatistics, and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. vgandhi@mdanderson.org
作者：
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿糖核苷类(Arabinonucleosides);阿糖核苷酸类(Arabinonucleotides);女(雌)性(Female);鸟苷三磷酸(Guanosine Triphosphate);人类(Humans);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);白血病, 幼淋巴细胞(Leukemia, Prolymphocytic);男(雄)性(Male);中年人(Middle Aged);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);预后(Prognosis);治疗结果(Treatment Outcome);阿糖腺苷(Vidarabine)
DOI
10.1200/JCO.2001.19.8.2142
PMID
11304766
发布时间
2017-02-10
基金项目
CA32839/CA/NCI NIH HHS/United States
CA57629/CA/NCI NIH HHS/United States
CA81534/CA/NCI NIH HHS/United States
- 浏览18
Journal of clinical oncology
2142-52页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
